DKSH has been at the forefront of supporting Thailand’s COVID-19 vaccine rollout since the country’s very first vaccine shipment arrived in February of 2021.
Bangkok, Thailand, March 9, 2021 – DKSH Business Unit Healthcare was instrumental in ensuring the inoculation of Thais across the kingdom. Now, the company celebrates its milestone of delivering over 70 million doses of the COVID-19 vaccines on behalf of the Thai government and various partners. An essential driving force in the fight against COVID-19, DKSH has delivered vaccines from various manufacturers to hospitals nationwide.
This milestone was made possible through DKSH’s extensive Healthcare infrastructure and capillary distribution network, supported by a workforce of over 3,000 specialists who worked tirelessly to ensure that the COVID-19 vaccines are delivered in a reliable and efficient manner. Thanks to its cold chain excellence and unique Vaccine Solutions Management system, which encompasses everything from warehousing to point of care management, DKSH has the capabilities and expertise to manage the storage and distribution of COVID-19 vaccines, cold chain products, medicines, and medical devices for local and international healthcare businesses. DKSH is proud to be a part of this rapid inoculation scale-up at the national level which has improved the wellbeing of many patients and healthcare professionals, reflecting the company’s core purpose of enriching people’s lives.
John Clare, Vice President, Business Unit Healthcare, DKSH Thailand and Indochina, commented: “DKSH has set the pace for COVID-19 vaccine delivery and is leading the way towards the future of healthcare, whereby state-of-the-art cold chain solutions will become increasingly important. As one of Asia’s biggest Healthcare service providers, we are committed to using our extensive capabilities to continue driving equitable access to the vaccines and contribute towards safeguarding public health and safety.”
About DKSH
DKSH’s purpose is to enrich people’s lives. For more than 150 years, we have been delivering growth for companies in Asia and beyond across our Business Units Healthcare, Consumer Goods, Performance Materials, and Technology. As a leading Market Expansion Services provider, we offer sourcing, market insights, marketing and sales, eCommerce, distribution and logistics as well as after-sales services. Listed on the SIX Swiss Exchange, DKSH operates in 36 markets with 33,100 specialists, generating net sales of CHF 11.1 billion in 2021. The DKSH Business Unit Healthcare distributes pharmaceuticals, consumer health and over-the-counter (OTC) products as well as medical devices. With around 7,290 specialists, the Business Unit generated net sales of CHF 5.6 billion in 2021. www.dksh.com/hec